31 / 68
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015
AFRICA
129
References
1.
Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic
kidney disease: common, harmful, and treatable – World Kidney Day
2007.
Clin J Am Soc Nephrol
2007;
2
(2): 401–405.
2.
Meguid El Nahas A, Bello AK. Chronic kidney disease: the global chal-
lenge.
Lancet
2005;
365
(9456): 331–340.
3.
Shaw C, Sharpe CC. Could Sickle cell trait be a predisposing risk factor
for CKD?
Nephrol Dial Transplant
2010;
25
: 2403–2405.
4.
Iyengar SK, Schelling JR, Sedor JR. Approaches to understanding
susceptibility to nephropathy: from genetics to genomics.
Kidney Int
2002;
61
(1Suppl): S61–67.
5.
Cavanaugh KL, Lanzkron S. Time to recognize an overlooked trait.
J
Am Soc Nephrol
2010;
21
: 383–394.
6.
Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman P,
et al
.
Sickle cell trait is not independently associated with susceptibility to
end-stage renal disease in African Amercians.
Kidney Int
2011;
80
(12):
1339–1343.
7.
Key NS, Derebail VK. Sickle cell trait: Novel clinical significance.
Hematology Am Soc Hematol Educ Program
2010;
2010
: 418–422.
8.
Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar
AV. High prevalence of sickle cell trait in African Americans with
ESRD.
J Am Soc Nephrol
2010;
21
: 413–417.
9.
Weatherall DJ. The inherited diseases of hemoglobin are an emerging
global health burden.
Blood
2010;
115
(22): 4331–4336.
10. Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2
diabetic complications in African patients.
Eur J Intern Med
2004;
15
:
312–315.
11. Sumaili EK, Nseka MN, Lepira FB, Krzesinski JM, Makulo JR,
Bukabau JB,
et al.
Screening for proteinuria and chronic kidney disease
risk factors in Kinshasa: a World Kidney 2007 study.
Nephron Clin Pract
2008;
110
(4): c220–228.
12. Tshilolo L, Aissi LM, Lukusa D, Kinsiama C, Wembonyama S, Gulbis
B, Vertongen F. Neonatal screening for sickle cell anaemia in the
Democratic Republic of the Congo: experience from a pioneer project
on 31 204 newborns.
J Clin Pathol
2009;
62
(1): 35–38.
13. Agasa B, Bosunga K, Opara A, Tshilumba K, Dupont E, Vertongen
F,
et al.
Prevalence of sickle cell disease in a northeastern region of the
Democratic Republic of Congo: what impact on transfusion policy?
Transfus Med
2010;
20
(1): 62–65.
14. Codreanu L, Perico N, Sharma SK, Schieppati A, Remuzzi G.
Prevention programmes of progressive renal disease in developing
nations.
Nephrology
2006;
11
(4): 321–328.
15. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W,
et al.
Smoking as a risk factor for end-stage renal failure in men with primary
renal disease.
Kidney Int
1998;
8
: 926–931.
16. World Health Organisation. Obesity: Preventing and managing the
global epidemic. Report of a WHO Consultation.
WHO Organ Techn
Rep Ser
2000;
894
: I–XII, 1–253.
17. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato
KA,
et al
. Harmonizing the metabolic syndrome: a joint interim
statement of the International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung, and Blood
Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International Association for
the Study of Obesity.
Circulation
2009;
120
(16): 1640–1645.
18. Guidelines Committee 2007 European Society of Hypertension–
European Society of Cardiology guidelines for the management of
arterial hypertension.
J Hypertens
2007;
25
: 1105–1187.
19. Friedewald WT, Levi RI, Fredrickson DS. Estimation of the concentra-
tion of LDL-cholesterol without use of the preparative ultracentrifuge.
Clin Chem
1972;
18
: 499–508.
20. Report of the Expert Committee on the diagnosis and classification of
diabetes mellitus.
Diabetes Care
2003;
26
(Suppl1): S5–20.
21. Bayauli MP, Lepira FB, Kayembe PK, M’buyamba-Kabangu JR. Left
ventricular hypertrophy and geometry in type 2 diabetes patients with
chronic kidney disease. An echocardiographic study.
Cardiovasc J Afr
2012;
23
(2): 73–77.
22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendricksen S,
et al.
Using standardized serum creatinine values in the Modification of
Diet in Renal Disease Study.
Kidney Int
1997;
51
: 1908–1919.
23. Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P,
Munyanga SM, Nseka NM. Prevalence of chronic kidney disease in
Kinshasa: results of a pilot study from the Democratic Republic of
Congo.
Nephrol Dial Transplant
2009;
24
(1): 117–122.
24. Longo AL, Lepira FB, Sumaili EK, Makulo JR, Mukumbi H, Bukabau
JB,
et al
. Prevalence of low estimated glomerular filtration rate, protein-
uria, and associated risk factors among HIV-infected black patients
using Cockroft-Gault and modification of diet in renal disease study
equations.
J Acquir Immune Defic Syndr
2012;
59
(1): 59–64.
25. National Kidney Foundation K/DOQI clinical practical guidelines
for chronic kidney disease: evaluation, classification and stratification.
Kidney Disease Outcome Quality Initiative.
Am J Kidney Dis
2002;
39
(2Suppl): S22–26.
26. Bleyer AJ, Reddy SV, Sujata L, Russell GB, AkinnifesI D, Bleyer AJ Jr,
et al
. Sickle cell trait and development of microvascular complications in
diabetes mellitus.
Clin J Am Soc Nephrol
2010;
5
: 1015–1020.
27. Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung JC. Metabolic
syndrome and insulin resistance as risk factors for development of
chronic kidney disease and rapid decline in renal function in elderly.
J
Clin Endocrinol Metab
2012;
97
(4): 1268–1276.
28. Thomas G, Sehger AR, Kashyap SR, Srinivas TR, Kirwan JP,
Navaneethan SD. Metabolic syndrome and kidney disease: a system-
atic review and meta-analysis.
Clin J Am Soc Nephrol
2011;
6
(10):
2364–2373.
29. Tanner RM, Brown TM, Muntner P. Epidemiology of obesity, meta-
bolic syndrome and chronic kidney disease.
Curr Hypertens Rep
2012;
14
(2): 152–159.
30. Chen J, Muntner P, Hamon LL, Jones DW, Batuman V, Fonseca V,
et al.
The metabolic syndrome and chronic kidney disease in US adults.
Ann
Intern Med
2004;
140
(3): 167–174.
31. Liao MT, Sung CC, Hung KC, Wu CC, Le L, Lu KC. Insulin resistance
in patients with chronic kidney disease.
J Biomed Biotechnol
2012;
2012
:
691369. Doi: 10.1155/2012/691369.
32. Prieto D, Contreras C, Sanchez A. Endothelial dysfunction, obesity and
insulin resistance.
Curr Vasc Pharmacol
2014;
12
(3): 412–426.